DK147422C - Analogifremgangsmaade til fremstilling af phosphonoacylproliner - Google Patents

Analogifremgangsmaade til fremstilling af phosphonoacylproliner

Info

Publication number
DK147422C
DK147422C DK353378A DK353378A DK147422C DK 147422 C DK147422 C DK 147422C DK 353378 A DK353378 A DK 353378A DK 353378 A DK353378 A DK 353378A DK 147422 C DK147422 C DK 147422C
Authority
DK
Denmark
Prior art keywords
preparing
analogy procedure
phosphonoacyl
prolines
phosphonoacyl prolines
Prior art date
Application number
DK353378A
Other languages
English (en)
Other versions
DK147422B (da
DK353378A (da
Inventor
Miguel A Ondetti
Edward W Petrillo
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DK353378A publication Critical patent/DK353378A/da
Publication of DK147422B publication Critical patent/DK147422B/da
Application granted granted Critical
Publication of DK147422C publication Critical patent/DK147422C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK353378A 1977-08-11 1978-08-10 Analogifremgangsmaade til fremstilling af phosphonoacylproliner DK147422C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82381877A 1977-08-11 1977-08-11
US82381877 1977-08-11

Publications (3)

Publication Number Publication Date
DK353378A DK353378A (da) 1979-02-12
DK147422B DK147422B (da) 1984-07-30
DK147422C true DK147422C (da) 1985-02-11

Family

ID=25239818

Family Applications (1)

Application Number Title Priority Date Filing Date
DK353378A DK147422C (da) 1977-08-11 1978-08-10 Analogifremgangsmaade til fremstilling af phosphonoacylproliner

Country Status (11)

Country Link
US (1) US4151172A (da)
EP (1) EP0000833B1 (da)
JP (1) JPS5430158A (da)
AU (1) AU523323B2 (da)
CA (1) CA1109476A (da)
DE (1) DE2860019D1 (da)
DK (1) DK147422C (da)
HU (1) HU176712B (da)
IE (1) IE47170B1 (da)
IT (1) IT1098006B (da)
NO (1) NO149923C (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316896A (en) * 1978-09-07 1982-02-23 Merck & Co., Inc. Aminoacid derivatives as antihypertensives
US4690937A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
US4698356A (en) * 1979-08-14 1987-10-06 University Of Miami Anti-hypertensive agents
US4690940A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
US4690939A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4698355A (en) * 1979-08-14 1987-10-06 University Of Miami Anti-hypertensive agents
US4690938A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
US4695577A (en) * 1979-08-14 1987-09-22 University Of Miami Anti-hypertensive agents
US4168267A (en) * 1978-10-23 1979-09-18 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl prolines
US4734420A (en) * 1980-03-05 1988-03-29 University Of Miami Anti-hypertensive agents
US4690936A (en) * 1980-03-05 1987-09-01 University Of Miami Anti-hypertensive agents
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives
US4416831A (en) * 1981-04-27 1983-11-22 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinylalkanoyl compounds
US4374131A (en) * 1981-04-27 1983-02-15 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinyl-alkanoyl compounds
US4416833A (en) * 1981-05-04 1983-11-22 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
US4381297A (en) * 1981-05-04 1983-04-26 E. R. Squibb & Sons, Inc. Substituted carbonyl phosphinyl-alkanoyl compounds
EP0070131A1 (en) * 1981-07-09 1983-01-19 Analytical Research Pharmaceuticals Pty. Ltd. Phosphonoalkanoylamino acids
US4432971A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4371526A (en) * 1981-08-21 1983-02-01 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted 4,5-dihydropyrazole-5-carboxylic acid derivatives and hypotensive method and composition
US4555506A (en) * 1981-12-24 1985-11-26 E. R. Squibb & Sons, Inc. Phosphorus containing compounds and use as hypotensives
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4452791A (en) * 1982-03-15 1984-06-05 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
EP0091525A3 (en) * 1982-04-08 1984-02-29 Analytical Research Pharmaceuticals Pty. Ltd. Phosphonoalkanoylamino acids
US4448772A (en) * 1982-04-22 1984-05-15 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
US4560681A (en) * 1982-04-22 1985-12-24 E. R. Squibb & Sons, Inc. Phosphinylmethylaminocarbonyl imino acid compounds useful for treating hypertension
CA1258853A (en) * 1982-04-30 1989-08-29 Rudiger D. Haugwitz Substituted 4-phenoxy prolines
US4616005A (en) * 1982-06-23 1986-10-07 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4703043A (en) * 1982-06-23 1987-10-27 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensive
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4567166A (en) * 1982-07-14 1986-01-28 E. R. Squibb & Sons, Inc. Amino and substituted amino phosphinylalkanoyl compounds useful for treating hypertension
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
JPH0624706B2 (ja) * 1985-10-01 1994-04-06 ミネソタ マイニング アンド マニユフアクチユアリング コンパニ− 研磨パツド
CA2021409A1 (en) * 1989-08-21 1991-02-22 Donald S. Karanewsky Phosphonate substituted amino or imino acids useful as antihypertensives
DE3939142A1 (de) * 1989-11-27 1991-05-29 Hoechst Ag Verfahren zur oxidation von 2-hydroxy-aethylphosphonsaeuredialkylestern
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US5863536A (en) * 1996-12-31 1999-01-26 Guilford Pharmaceuticals Inc. Phosphoramidate derivatives
US5902817A (en) * 1997-04-09 1999-05-11 Guilford Pharmaceuticals Inc. Certain sulfoxide and sulfone derivatives
US5977090A (en) * 1996-09-27 1999-11-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
US6054444A (en) 1997-04-24 2000-04-25 Guilford Pharmaceuticals Inc. Phosphonic acid derivatives
US6384022B1 (en) 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
TR199802638T2 (xx) 1996-06-17 1999-03-22 Guilford Pharmaceuticals, Inc. Kanser tedavisinde naaladase inhibit�rleri kullan�m�.
US6025344A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
US6025345A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6071965A (en) * 1996-06-17 2000-06-06 Guilford Pharmaceuticals Inc. Phosphinic alkanoic acid derivatives
US5962521A (en) 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
US5981209A (en) * 1997-12-04 1999-11-09 Guilford Pharmaceuticals Inc. Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US6028216A (en) * 1997-12-31 2000-02-22 Guilford Pharmaceuticals Inc. Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
CZ200113A3 (cs) 1998-07-06 2001-08-15 Guilford Pharmaceuticals Inc. Inhibitory NAALAdázy využitelné jako léčiva a farmaceutické kompozice, které je obsahují
US6265609B1 (en) 1998-07-06 2001-07-24 Guilford Pharmaceuticals Inc. Thio-substituted pentanedioic acid derivatives
US6395718B1 (en) 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
ITMI20010395A1 (it) 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
ES2312834T3 (es) 2002-12-10 2009-03-01 Dompe S.P.A. Arilcetonas quirales en el tratamiento de enfermedades inflamatorias dependientes de neutrofilos.
EP2519100B1 (en) 2009-12-29 2017-03-15 Mapi Pharma Limited Intermediate compounds and processes for the preparation of tapentadol and related compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048156A (en) * 1968-05-24 1977-09-13 E. I Du Pont De Nemours And Company Carbamoylphosphonates
US4025332A (en) * 1974-10-01 1977-05-24 Monsanto Company Increasing sucrose content of sugarcane plants with N-phosphonomethylglycinamides
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives

Also Published As

Publication number Publication date
DK147422B (da) 1984-07-30
US4151172A (en) 1979-04-24
IE781619L (en) 1979-02-11
CA1109476A (en) 1981-09-22
NO149923C (no) 1984-07-18
DK353378A (da) 1979-02-12
EP0000833B1 (en) 1981-09-02
IT7826549A0 (it) 1978-08-07
EP0000833A1 (en) 1979-02-21
JPS5430158A (en) 1979-03-06
NO149923B (no) 1984-04-09
IT1098006B (it) 1985-08-31
DE2860019D1 (en) 1981-04-23
AU523323B2 (en) 1982-07-22
NO782724L (no) 1979-02-13
AU3843678A (en) 1980-01-31
HU176712B (en) 1981-04-28
IE47170B1 (en) 1984-01-11

Similar Documents

Publication Publication Date Title
DK147422C (da) Analogifremgangsmaade til fremstilling af phosphonoacylproliner
DK195378A (da) Fremgangsmaade til fremstilling af polyenforbindelser
DK155733C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK349478A (da) Fremgangsmaade til fremstilling af oligoimider
DK155603C (da) Analogifremgangsmaade til fremstilling af benzimidazolderivater
DK539578A (da) Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK109578A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK155279C (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-oxo-pyrrolidinderivater
DK531178A (da) Fremgangsmaade til fremstilling af phenylglycinderivater
DK364178A (da) Fremgangsmaade til fremstilling af antibiotikum
DK109478A (da) Fremgangsmaade til fremstilling af polypeptider
DK265978A (da) Fremgangsmaade til fremstilling af substituerede guanidiner
DK470978A (da) R fremgangsmaade til fremstilling af pyrazinobenzoxapinderivate
DK427878A (da) Fremgangsmaade til fremstilling af hidtil ukendte thiopropionamider
DK151078A (da) Fremgangsmaade til fremstilling af cyclobutanoner
DK152130C (da) Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK494978A (da) Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK439878A (da) Fremgangsmaade til fremstilling af laktamforbindelser
DK262678A (da) Fremgangsmaade til fremstilling af quinolinonderivater
DK547978A (da) Fremgangsmaade til fremstilling af pyrrolidinderivater
DK142848C (da) Analogifremgangsmaade til fremstilling af 2-acylamido-4-amino-5-benzylpyrimidinforbindelser
DK147197C (da) Analogifremgangsmaade til fremstilling af 2-hydrazonopropionsyrederivater
DK31478A (da) Fremgangsmaade til fremstilling af aralkylaniliner
DK26378A (da) Fremgangsmaade til fremstilling af arginforbindelser
DK385478A (da) Fremgangsmaade til fremstilling af dibenzocycloocteniminer

Legal Events

Date Code Title Description
PBP Patent lapsed